Synthesis and serotonergic activity of a series of 2-(JV-benzyl)carboxamido-5-substituted-N,N-dimethyltryptamine derivatives: Novel antagonists for the vascular 5-HT1B-like receptors

Journal of the Chemical Society - Perkin Transactions 1

Volumn , Issue 19, 1999, Pages 2699-2711

  Moloney, Gérard P ^a   Martin, Graeme R ^a   Mathcws, Neil ^b   Hobbs, Heather ^b   Dodsworth, Susan ^b   Sang, Pang Yih ^c   Knight, Cameron ^c   Maxwell, Miles ^a   Glen, Robert C ^a  

^a MONASH UNIVERSITY   (Australia)

^b Nenrobiology Unit   (United States)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000305387     PISSN: 0300922X     EISSN: None     Source Type: Journal    
DOI: 10.1039/a903141c     Document Type: Article

References (43)

1. M.M. Rapport, A. A. Green and I. H. Page, Fed. Proc., 1947, 6, 184.
2. (a) C. Gluchowski, T.A. Branchek, R. L. Weinshank and P. R. Hartig, Anna. Rep. A fed Chan., 1993, 28, 29;
3. (b) P.R. Hartig, N. Adham, J. Zgombick, R. Weinshank and T. Branchek, Drug. Dev. Res., 1992,26,215.
4. G.R. Martin and P. P. A. Humphrey, Neuropliarinacology, 1994,33, 261.
5. D. Hoyer, D.E. Clarke, J. R. Fozard, P. R. Hartig, G. R. Martin, E. J. Mylecharane, P. R. Saxena and P. Humphrey, Pliarmacol. Rev., 1994,46,157.
6. E. Zifa and G. Pillion, Pharmacol. Rer., 1992, 44,401.
7. D. Hoyer and G.R. Martin. Neuropliarinacology, 1997, in press.
8. P.M. Vanhoutte, P. P. A. Humphrey and M. Spedding, Pharmacol. Rev., 1996,48,1.
9. P.R. Hartig. D. Hoyer, P. P. A. Humphrey and G. R. Martin, Trends. Pharmacol. Sci., 1996,17, 103.
10. P.P. A. Humphrey, W. Feniuk, M. J. Perren, H. E. Connor, A. W. Oxford, I. H. Coates and D. Butina, Br. J. Pharmacol., 1988, 94, 1123.
11. K.L. Dechant and S. P. Clissold, Drugs, 1992,43, 776. IIP. C. North, Migraine Therapy - Serotonin. to Sumatriptan in Medicinal Chemistry: Principles and Practice, ed. F. G. King, The Royal Society of Chemistry, 1994.
12. R.C. Glen, A. P. Hill, G. R. Martin and A. D. Robertson, Headache, 1994,34, 307.
13. R.C. Glen, G. R. Martin, A. P. Hill, R. M. Hyde, P. M. Woollard, J. A. Salmon, J. Buckincham and A. D. Robertson, J. Med. Chem., 1995,38, 3566.
14. L.J. Street, R. Baker, J. L. Castro, M. S. Chambers, A. R. Guiblin, S. C. Hobbs, V. G. Matassa, A. J. Reeve, M. S. Beer, D. N. Middlemiss, A. J. Noble, J. A. Stanton, K. Scholey and R. J. Hargreaves, J Med. Chem., 1993,36, 1529.
15. P. Schoeffter and D. Hoyer, Naunyn - Schmiedeberg's Arch. Pharmacol., 1989,340, 135.
16. S.J. Peroutka and B. G. McCarthy, Eur. J. PliarmacoL, 1989, 163, 133.
17. E. Hamel, Current Drugs: Serotonin ID Research Alert, 1996, l, 19.
18. G.R. Martin, Serotonin Receptor Involvement in the Palhogenesis and Treatment of Migraine, in: Blue Books on Neurology, eds S. Silberstein and P. J. Goadsby, Buttenvorth-Heinemann, 1997.
19. E.P. McFadden, J. G. Clarke, G. J. Davies, J. C. Kaski, A. W and M. A. Maseri, New Eng. J. Med., 1991,324, 648.
20. P. Golino, F. Piscione, J.T. Willerson, M. Cappelli-Bigazzi, A. Focaccio, B. Villari, C. Indolfi, E. Russolillo, M. Condorelli and M. Chiariello, Neu- Eng. J. Med., 1991,324, 641.
21. A. Maseri, Circulation, 1990,11-13.
22. D.J. Fitzgerald, L. Roy, F. Catella and G. A. Fitzgerald, New Engl. J. Med., 1986,315,983.
23. P.B. Bradley, G. Engel, W. Feniuk, J. R. Fozard, P. P. A. Humphrey, D. N. Middlemiss, E. J. Mylecharane, B. P. Richardson and P. R. Saxena, Neurophannacology, 1986, 25, 563.
24. A.L. Scherbel and J. N. Hàrrison, Angiology, 1959,10, 29.
25. (a) European Patent EP 0 533 266 A1,1992;
26. (b) European Patent EP 0 533 267 Al, 1992;
27. European Patent EP 0 533 268 Al, 1992;
28. J.W. Clitherow, D. I. C. Scopes, M. Skingle, C. C. Jordan, W. Feniuk, I. B. Campbell, M. C. Carter, E. W. Collington, H. E. Connor, G. A. Higgins, D. Beattie, H. A. Kelly, W. L. Mitchell, A. W. Oxford, A. H. Wadsworth and M. B. Tyers, J. Med. Client., 1994,37,2253.
29. M. Skingle, A.J. Sleight and S. Feniuk, Neuropharmacology, 1995, 34, 377.
30. D.M. Walsh, D. T. Beattie and H. E. Connor, Eur. J. Pharmacol., 1995,287, 79.
31. G.P. Moloney, A. D. Robertson, G. R. Martin, S. MacLennan, N. Mathews, S. Dodsworth, Pang Yih Sang, C. Knight and R. C. Glen, J Med. Client., 1997,40,2347.
32. G.P. Moloney, G. R. Martin, N. Mathews, H. Hobbs, S. Dodsworth, Pang Yih Sang, C. Knight, M. Williams, M. Maxwell and R, C. Glen, J. Med. Cliem., 1999, submitted.
33. (a) O. Mitsunobu, Synthesis, 1981, 1;
34. (b) D.L. Hughes, Org. React., 1992,42,335.
35. (a) I. Koppel, J. Koppel, F. Degerbeck, L. Grehn and U. Ragnarsson, J. Org. Client., 1991, 56, 7172;
36. (b) J.R. Henry, L. R. Marcin, M. C. Mclntosh, P. M. Scola, G. D. Harris, Jr and S. M. Weinreb, Tetrahedron Lett., 1989, 30, 5709;
37. O. Mitsunobu, M. Wada and T. Sano, J. Am. Client. Soc., 1972,94,679.
38. R.R. Phillips, Org. React., 1959,10, 143.
39. F.R. Japp and P. Klingemann in Methoden der organischen Chemie, (Houben-Weyl-Muller) Bd. Xβ, S. 523, Thieme-Verlag, Stuttgart 1965.
40. B. Robinson, The Fischer Indole Synthesis, John Wiley and Sons: New York, 1982.
41. G.R. Martin and S. J. MacLennan, Naitnyn - Schmiedeberg's. Arch. Pharmacol., 1990,342,111.
42. S.J. MacLennan and G. R. Martin, Br. J. Pharmacol, 1992, 107, 418.
43. Sybyl 6. l molecular modelling package. Tripos Associates, St Louis MO 63144, U.S.A. 1992.